ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Impact of postoperative chemotherapy in patients with locally advanced gastroesophageal adenocarcinoma treated with perioperative chemotherapy strategy

Thursday, June 11, 2015

Submitted by

Mark Ferguson

Source

Source Name: American Journal of Surgery

Source URL: http://www.americanjournalofsurgery.com/article/S0002-9610%2815%2900132-4/abstra…

Author(s)

Guillaume Luc, Hélène Gersen-Cherdieu, Olivier Degrandi, Eric Terrebonne, Laurence Chiche, Denis Collet

This single institution retrospective analysis of esophagectomy or gastrectomy for GEJ cancer compared outcomes between groups who did and did not complete recommended 2 cycles of postoperative adjuvant chemotherapy. Of 110 pts who underwent perioperative chemotherapy, 67% completed postoperative adjuvant chemotherapy. Completion of 2 cycles or more of postoperative adjuvent chemotherapy was associated with improved survival.